According to Stratistics MRC, the Global 3D Cell Culture Market is accounted for $458.26 million in 2016 and is expected to reach $1,856.44 million by 2023 growing at a CAGR of 22.1% during the forecast period. Increasing investment and RD funding for cell based research, technological advancements, advantages of 3D culture techniques over 2D techniques, development of automated largescale cell culture systems and increasing demand for organ transplantation tissue engineering are some of the factors boosting the market growth. However, high cost of research, and dearth of infrastructure for research in developing countries are anticipated to hamper the market growth. Hence it is an opportunity for players to increase in RD spending in the growing market to gain the traction.
A 3D cell culture is an artificially created environment in which biological cells are permitted to grow or interact with their surroundings in all three dimensions. These 3D cultures are usually grown in bioreactors, small capsules in which the cells can grow into spheroids, or 3D cell colonies. Hospitals, pharmaceutical companies, research institutes and laboratories are adopting 3D cell culture for better outputs and the adoption rate is posed to increase rapidly during the forecast period.
By product, scaffoldbased segment dominated the global market with largest share owing to variety of material and structural choices for scaffold. In 2016, cancer and stem cell research segment is expected to grow with a high CAGR during the forecast period owing to rising prevalence rate of cancer and augmented investments in RD activities by both government and private sectors. North America accounted for largest share in the global market followed by Europe owing to rising government support, increasing incidence of cancer and introduction of new products in the market. However, Asia pacific is expected to witness the fastest growth over the forecast period.
Some of the key players profiled in the report include 3D Biomatrix, Inc., 3D Biotek LLC, Becton, Dickinson and Company, Corning Incorporated, Global Cell Solutions, Inc., InSphero AG, Lonza Group, Merck Co., Inc., Nano 3D Biosciences Inc, Nanofiber Solutions Incorporation, PromoCell GmbH, Reinnervate Ltd A subsidiary of ReproCELL, Sigma Aldrich Corporation, Tecan Trading AG, Thermo Fisher Scientific and VWR International LLC.
Products Covered:
Magnetic levitation 3D Bioprinting
Microfluidicsbased 3D Cell Culture
Scaffoldfree Cell Culture
Scaffoldbased 3D Cell Culture
Applications Covered:
Cancer and Stem Cell Research
Drug Discovery
Regenerative Medicine Tissue Engineering
Cell Based Assays/Toxicity Screening
In Vivo Applications for Stem Cells
3D Printing/Microfluidics
Other Applications
End Users Covered:
Research laboratories and institutes
Hospitals and diagnostic centers
Biotechnology and pharmaceutical industries
Other End Users
Regions Covered:
North America
o US
o Canada
o Mexico
Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
South America
o Argentina
o Brazil
o Chile
o Rest of South America
Middle East Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East Africa
What our report offers:
Market share assessments for the regional and country level segments
Market share analysis of the top industry players
Strategic recommendations for the new entrants
Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
Market Trends Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements
Original Article: 3D Cell Culture Global Market Outlook 20172023 [Report Updated: 01112017] Prices from USD $4150
NEXT ARTICLE